How TerrAscend is Preparing for Rescheduling | TTB Presented by Flowhub

About this episode

The episode discusses TerrAscend's Q1 2026 earnings and their strategies in light of cannabis rescheduling.

In our latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell sit down with leadership from TerrAscend (TSX:TSND) to break down Q1 2026 preliminary earnings and what’s actually happening under the hood.Chairman Jason Wild and CEO Ziad Ghanem join us to walk through the numbers following their preliminary Q1 release.Revenue came in around $65.5M—slightly down quarter-over-quarter, but back to year-over-year growth. Margins? Still holding strong north of 52%. And maybe most important—this marks another quarter of positive operating cash flow in what continues to be a tough pricing environment across key markets like New Jersey.So what’s the strategy here?Are they protecting margins… or sacrificing growth?We get into that.We also break down: What’s really happening in New Jersey as pricing pressure builds Maryland dynamics—retail vs wholesale Pennsylvania as a potential adult-use catalyst And how they’re thinking about M&A with debt pushed out to 2028 Then we shift to the bigger story…Cannabis rescheduling.With the Trump administration making it official last week, we ask how TerrAscend is preparing for what looks like a very different…

People in this episode

Hosts: Shadd Dales, Anthony Varrell

Guests: Jason Wild, Ziad Ghanem

Topics covered

• cannabis earnings
• TerrAscend
• rescheduling
• M&A strategy
• pricing pressure
• operating cash flow

Keywords

• TerrAscend
• cannabis stocks
• earnings season
• operating cash flow
• M&A
• pricing pressure
• New Jersey
• Maryland
• Pennsylvania

Sponsors

Flowhub

Mentioned in this episode

Organizations: TerrAscend, Trump administration

Places: New Jersey, Maryland, Pennsylvania

More episodes of The Dales Report | Trade to Black

• Big Changes Are Hitting The Cannabis Industry Now | TTB Presented by Flowhub · June 11, 2026 · 1h 10m
• Village Farms CEO Explains $15M Raise + Inside the CMS CBD Pilot | TTB Presented by Flowhub · June 11, 2026 · 1h 3m
• Why Pharma Is Taking Cannabis Seriously | Trade to Black · June 10, 2026 · 27 min
• Trulieve Goes Live, Uplisting Era Begins | TDR Cannabis in 5 · June 10, 2026 · 6 min
• Trulieve Makes NYSE Debut: What Investors Must Know | TTB Presented by Flowhub · June 10, 2026 · 1h 5m
• Trulieve Makes History on the NYSE | Indiana Signals Movement on Cannabis | TTB Presented by Flowhub · June 8, 2026 · 1h 3m